INEXAS: A Phase 2 Randomized Trial of On-demand Inhaled Interferon Beta-1a in Severe Asthmatics.
Journal Information
Full Title: Clin Exp Allergy
Abbreviation: Clin Exp Allergy
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Allergy and Immunology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"CONFLICTS OF INTEREST CM, MO, PG, AM, MA, MF, CAD, AC, JP, KK and CW are employees and shareholders of AstraZeneca. MK is a former employee of AstraZeneca. PM and RM are directors and shareholders in Synairgen plc. TH reports personal fees and non‐financial support from AstraZeneca and GlaxoSmithKline, and personal fees from Chiesi and Vectura, outside of the submitted work."
"Funding information This study was funded by AstraZeneca."
"Trial registration: Clinicaltrials.gov Identifier NCT02491684."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025